C

CSPC Pharmaceutical Group Ltd
HKEX:1093

Watchlist Manager
CSPC Pharmaceutical Group Ltd
HKEX:1093
Watchlist
Price: 6.21 HKD 1.31% Market Closed
Market Cap: 71.7B HKD

Intrinsic Value

The intrinsic value of one CSPC Pharmaceutical Group Ltd stock under the Base Case scenario is 7.32 HKD. Compared to the current market price of 6.21 HKD, CSPC Pharmaceutical Group Ltd is Undervalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
7.32 HKD
Undervaluation 15%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
CSPC Pharmaceutical Group Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CSPC Pharmaceutical Group Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CSPC Pharmaceutical Group Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on CSPC Pharmaceutical Group Ltd?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on CSPC Pharmaceutical Group Ltd’s research
View All Researches
CSPC Pharmaceutical Group Ltd
HKEX:1093
CN
Pharmaceuticals
Market Cap
72.3B HKD
IPO
Jun 21, 1994
CN
Pharmaceuticals
Market Cap
72.3B HKD
IPO
Jun 21, 1994
Price
HK$false
EPS
ÂĄfalse
AI Assistant
AI Assistant
Ask me anything about CSPC Pharmaceutical Group Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
CSPC Pharmaceutical Group Ltd

Current Assets 21.9B
Cash & Short-Term Investments 8.3B
Receivables 9.6B
Other Current Assets 4B
Non-Current Assets 22.5B
Long-Term Investments 6.3B
PP&E 12.5B
Intangibles 2.8B
Other Non-Current Assets 826.4m
Efficiency

Free Cash Flow Analysis
CSPC Pharmaceutical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CSPC Pharmaceutical Group Ltd

Revenue
29B CNY
Cost of Revenue
-8.7B CNY
Gross Profit
20.3B CNY
Operating Expenses
-14.4B CNY
Operating Income
5.9B CNY
Other Expenses
-1.6B CNY
Net Income
4.3B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

CSPC Pharmaceutical Group Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
Positive Free Cash Flow
60/100
Profitability
Score

CSPC Pharmaceutical Group Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CSPC Pharmaceutical Group Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Negative Net Debt
Low D/E
93/100
Solvency
Score

CSPC Pharmaceutical Group Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CSPC Pharmaceutical Group Ltd

Wall Street analysts forecast CSPC Pharmaceutical Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSPC Pharmaceutical Group Ltd is 6.74 HKD with a low forecast of 4.55 HKD and a high forecast of 12.6 HKD.

Lowest
Price Target
4.55 HKD
27% Downside
Average
Price Target
6.74 HKD
9% Upside
Highest
Price Target
12.6 HKD
103% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CSPC Pharmaceutical Group Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one CSPC Pharmaceutical Group Ltd stock?

The intrinsic value of one CSPC Pharmaceutical Group Ltd stock under the Base Case scenario is 7.32 HKD.

Is CSPC Pharmaceutical Group Ltd stock undervalued or overvalued?

Compared to the current market price of 6.21 HKD, CSPC Pharmaceutical Group Ltd is Undervalued by 15%.

Back to Top